KLS · Financial Statements
Genetec Technology Berhad (0104.KL) Financial Statements
$0.27
KLS: 0104.KL
Market Cap $247.40M
Full income statement, balance sheet, and cash flow statement for Genetec Technology Berhad (0104.KL), plus valuation and return ratios.
Annual financials are not yet available for this stock.
Valuation & Return Ratios
Genetec Technology Berhad (0104.KL) financials — frequently asked questions
What is 0104.KL EV/EBITDA?
Genetec Technology Berhad's enterprise value to EBITDA (EV/EBITDA) ratio is -2.29. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.